
Congress trades
Penumbra, Inc. (PEN)
NYSE · Healthcare · 6 congress trades · last filed 1 year ago
About Penumbra, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Adam Elsesser
- Employees
- 4,700
- Listed since
- Sep 18, 2015
- Market value
- $12.6B
- Price to earnings
- 78.1
- Earnings per share
- $4.08
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $0.88 | $1.16 | $390.0M | $389.6M | EPS missRevenue in line |
| Q1 FY2026reported May 6, 2026 | $0.82 | $1.04 | $374.8M | $370.5M | EPS missRevenue in line |
| Q4 FY2025reported Feb 25, 2026 | $1.18 | $1.11 | $385.4M | $361.9M | EPS beatRevenue beat |
| Q3 FY2025reported Nov 5, 2025 | $0.97 | $0.93 | $354.7M | $341.0M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 29, 2025 | $0.86 | $0.81 | $339.5M | $341.3M | EPS beatRevenue in line |
| Q1 FY2025reported Apr 23, 2025 | $0.83 | $0.66 | $324.1M | $327.3M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 29, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Shruthi NarayanPresident | $731K | $3.6M | $7K | $4.4M |
| Maggie YuenChief Financial Officer | $715K | $1.7M | $7K | $2.4M |
| Johanna RobertsExecutive Vice President, General Counsel and Secretar | $715K | $1.7M | $7K | $2.4M |
| Lambert ShiuChief Accounting Officer | $594K | $1.6M | $7K | $2.2M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $1.4B | 4,297,555 | -0.8% | 10.93% |
| HBK Investments L P | $580.5M | 1,838,508 | +12.5% | 4.68% |
| Vanguard Capital Management LLC | $539.9M | 1,709,877 | +0.9% | 4.35% |
| Vanguard Portfolio Management LLC | $526.4M | 1,667,276 | +0.8% | 4.24% |
| State Street Corp | $392.6M | 1,243,258 | +4.8% | 3.16% |
| Exoduspoint Capital Management, LP | $344.3M | 1,090,430 | +134.4% | 2.77% |
| Balyasny Asset Management L.P. | $344.2M | 1,090,163 | +43.0% | 2.77% |
| Jpmorgan Chase & Co | $338.6M | 1,071,454 | +166.1% | 2.73% |
| Goldman Sachs Group Inc | $267.5M | 847,104 | +17.6% | 2.15% |
| Arrowstreet Capital, Limited Partnership | $263.6M | 834,903 | +108.6% | 2.12% |
| Geode Capital Management, LLC | $251.5M | 796,471 | +0.1% | 2.03% |
| Norges Bank | $237.5M | 752,242 | +100.0% | 1.91% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in PEN
6 disclosures of 6 on record · median 31d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +31.1%S&P +22.0% · vs S&P 500 +9.1% | Jul 10, 2025 | Aug 13, 2025 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +140.8%S&P +96.3% · vs S&P 500 +44.5% | Jun 27, 2022 | Jul 7, 2022 | 10d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +126.3%S&P +91.9% · vs S&P 500 +34.3% | May 10, 2022 | Jun 10, 2022 | 31d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +124.1%S&P +93.0% · vs S&P 500 +31.1% | May 23, 2022 | Jun 10, 2022 | 18d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +107.7%S&P +85.0% · vs S&P 500 +22.6% | May 5, 2022 | Jun 10, 2022 | 36d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +46.3%S&P +74.8% · vs S&P 500 -28.6% | Jan 21, 2022 | Feb 8, 2022 | 18d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 9, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded PEN?
Lisa C. McClain, Ro Khanna disclosed PEN transactions in the filings shown here.
How quickly are PEN trades disclosed?
Congressional disclosures took a median of 31 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
